Investors
Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)
Announcements
Introducing Opin: Using AI to match patients to clinical trials anywhere in the world
downloadOpyl appoints Dr Megan Robertson to its Board
downloadOpyl completes oversubscribed share purchase plan
downloadClinical trial recruitment platform achieves first major milestone
downloadOpyl completes unmarketable parcel share buy-back
downloadOpyl Implements Unmarketable Parcel Share Sale Facility
downloadGovernance
Share Purchase Plan Offer Booklet
downloadOpyl – 2020 Corporate Governance Statement
downloadOpyl – Audit and Risk Committee Charter 2020
downloadOpyl – Board Charter 2020
downloadOpyl – Code of Conduct (New) 2020
downloadOpyl – Diversity Policy 2020
downloadOpyl – Remuneration and Nomination Committee Charter 2020
downloadOpyl – Trading Policy (New) 2020
downloadOpyl – Whistleblower (New) 2020
downloadOpyl Disclosure and Communication Policy Update 2020
downloadBoard and Management Team
Dr Julian Chick
Chairman
Michelle Gallaher
Chief Executive Officer
Damon Rasheed
Executive Director
Marat Basyrov
Non Executive Director
Mark Ziirsen
Non Executive Director
David Iilja
Company Secretary